ALB001

Indicaton

First personalized, orally available medicine against Rheumatoid arthritis

Therapeutic indications

Inflammation

Type of product

Small molecule

Table

Phase

Discovery
Available in

EU, US, Switzerland

You may also be interested in

AUP-16 (AUP1602-C)

AUP-16 is a multi-therapy live bacterial vector for chronic wounds: Diabetic Foot, Leg & Pressure Ulcers

Phase II started

Veblocema (infliximab SC)

Multiple indications in rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis and psoriasis

Marketed

Remsima (infliximab IV)

Multiple indications in rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis and psoriasis

Marketed